TREA

79325753 - OMERO PLUS

Follow

Information

  • Trademark
  • 79325753
  • Serial Number
    79325753
  • Registration Number
    7497634
  • Filing Date
    August 31, 2021
    3 years ago
  • Registration Date
    September 10, 2024
    7 months ago
  • Transaction Date
    April 05, 2025
    6 days ago
  • Status Date
    September 10, 2024
    7 months ago
  • Published for Opposition Date
    November 29, 2022
    2 years ago
  • Location Date
    September 09, 2024
    7 months ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    HOWARD, PARKER
  • Attorney Name
    STACEY J WATSON
  • Owners
Information
Mark Drawing Code
3
Mark Identification
OMERO PLUS
Case File Statements
  • DM0000: The mark consists of a hexagon shape formed of six oblong triangles where three of them are dark blue, one of them is light green, one is dark green and one is light blue; in the center of the shape is a dark blue circle; to the right of the hexagon shape is a dark blue plus symbol and the wording "OMERO PLUS" where the "O" is light green, the "M" is dark green, the "E" is light blue, the "RO" is dark blue and the "PLUS" is light blue. The color white represents background and/or transparent areas and is not claimed as a feature of the mark.
  • GS0091: Downloadable computer software that is downloaded and installed for use in connection with the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; downloadable computer software that is downloaded and installed from the Internet for use in connection with the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; downloadable data access and data management software tools that are downloaded and installed for use in connection with the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; downloadable electronic publications in the nature of scientific journals, periodicals and newsletters relating to the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; none of the foregoing for use by clinical care providers, future or current patients, or their families in connection with pharmaceuticals, biopharmaceuticals or therapeutic methods, or produced, designed, or marketed for providing medical and scientific research summaries, reports, or opinions regarding the efficacy, safety, pharmacological characteristics, or other properties of pharmaceutical and biopharmaceutical products, product candidates, development programs, therapeutic methods, drug delivery systems, medical treatments, or diagnostic methods, and relating to a specific disease, disorder, or category thereof.
  • CC0000: The color(s) light green, dark green, light blue and dark blue is/are claimed as a feature of the mark.
  • GS0351: Business services relating to the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science, namely, management of biological and biomedical data and images for business enterprises; data processing services relating to the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; information, advisory and consultancy services in connection with the aforesaid services; none of the foregoing for use by clinical care providers, future or current patients, or their families in connection with pharmaceuticals, biopharmaceuticals or therapeutic methods, or produced, designed, or marketed for providing medical and scientific research summaries, reports, or opinions regarding the efficacy, safety, pharmacological characteristics, or other properties of pharmaceutical and biopharmaceutical products, product candidates, development programs, therapeutic methods, drug delivery systems, medical treatments, or diagnostic methods, and relating to a specific disease, disorder, or category thereof.
  • GS0451: Licensing of computer software for use in connection with the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; information, advisory and consultancy services in connection with the aforesaid services; none of the foregoing for use by clinical care providers, future or current patients, or their families in connection with pharmaceuticals, biopharmaceuticals or therapeutic methods, or produced, designed, or marketed for providing medical and scientific research summaries, reports, or opinions regarding the efficacy, safety, pharmacological characteristics, or other properties of pharmaceutical and biopharmaceutical products, product candidates, development programs, therapeutic methods, drug delivery systems, medical treatments, or diagnostic methods, and relating to a specific disease, disorder, or category thereof.
  • GS0421: Design and development of computer software, data access and data management software tools for use in connection with the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; computer programming; installation, maintenance and repair of computer software; design of computer websites and maintenance thereof, all relating to the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; software as a service (SaaS) featuring software for accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; information, advisory and consultancy services in connection with the aforesaid services; none of the foregoing for use by clinical care providers, future or current patients, or their families in connection with pharmaceuticals, biopharmaceuticals or therapeutic methods, or produced, designed, or marketed for providing medical and scientific research summaries, reports, or opinions regarding the efficacy, safety, pharmacological characteristics, or other properties of pharmaceutical and biopharmaceutical products, product candidates, development programs, therapeutic methods, drug delivery systems, medical treatments, or diagnostic methods, and relating to a specific disease, disorder, or category thereof.
Case File Event Statements
  • 12/2/2021 - 3 years ago
    2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI
  • 12/6/2021 - 3 years ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/18/2021 - 3 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 10/5/2022 - 2 years ago
    13 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 12/10/2021 - 3 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 6/6/2022 - 2 years ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/9/2022 - 2 years ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/10/2022 - 2 years ago
    7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 6/27/2022 - 2 years ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 6/28/2022 - 2 years ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 7/19/2022 - 2 years ago
    10 - REFUSAL PROCESSED BY IB Type: RFNP
  • 10/5/2022 - 2 years ago
    11 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 10/5/2022 - 2 years ago
    12 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 10/5/2022 - 2 years ago
    14 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 10/5/2022 - 2 years ago
    15 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 10/19/2022 - 2 years ago
    16 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/19/2022 - 2 years ago
    17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/20/2022 - 2 years ago
    18 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/26/2022 - 2 years ago
    22 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 10/26/2022 - 2 years ago
    19 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 10/26/2022 - 2 years ago
    20 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 10/26/2022 - 2 years ago
    21 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 10/26/2022 - 2 years ago
    23 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/9/2022 - 2 years ago
    24 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 11/23/2022 - 2 years ago
    25 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 11/23/2022 - 2 years ago
    26 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 11/29/2022 - 2 years ago
    27 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/29/2022 - 2 years ago
    28 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/30/2022 - 2 years ago
    29 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 4/19/2023 - a year ago
    32 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 12/12/2022 - 2 years ago
    30 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 4/19/2023 - a year ago
    31 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 5/9/2023 - a year ago
    33 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 5/27/2023 - a year ago
    34 - OPPOSITION NOTICE (IB REFUSAL) CREATED Type: OPNC
  • 5/29/2023 - a year ago
    35 - OPPOSITION NOTICE (IB REFUSAL) SENT TO IB Type: OPNS
  • 6/1/2023 - a year ago
    36 - OPPOSITION INSTITUTED NO. 999999 Type: OP.I
  • 6/26/2023 - a year ago
    37 - REFUSAL PROCESSED BY IB Type: RFNT
  • 8/7/2024 - 8 months ago
    38 - OPPOSITION DISMISSED NO. 999999 Type: OP.D
  • 8/7/2024 - 8 months ago
    39 - OPPOSITION TERMINATED NO. 999999 Type: OP.T
  • 8/7/2024 - 8 months ago
    40 - TTAB RELEASE CASE TO TRADEMARKS Type: TMBN
  • 9/10/2024 - 7 months ago
    41 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 9/10/2024 - 7 months ago
    42 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 12/10/2024 - 4 months ago
    43 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 4/4/2025 - 7 days ago
    45 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 4/4/2025 - 7 days ago
    44 - FINAL DISPOSITION PROCESSED Type: FIMP